Latest News from: Georgetown Lombardi Comprehensive Cancer Center

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 80
ghi-5562.jpg
  • Embargo expired:
    24-Apr-2019 12:05 AM EDT

Article ID: 711607

Use of Genetic Testing in Women Diagnosed with Breast Cancer Decreases Cost of Care Nationwide

Georgetown Lombardi Comprehensive Cancer Center

A new study suggests that Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the U.S. by about $50 million (about 2 percent of the overall costs in the first year). The study by Georgetown Lombardi Comprehensive Cancer Center and National Cancer Institute researchers was published April 24, in JNCI.

Released:
19-Apr-2019 10:30 AM EDT
  • Embargo expired:
    16-Apr-2019 12:05 PM EDT

Article ID: 711277

Large Federal Program Aimed at Providing Better Health Care Underfunds Primary Care

Georgetown Lombardi Comprehensive Cancer Center

Despite a mandate to help patients make better-informed health care decisions, a ten-year research program established under the Affordable Care Act has funded a relatively small number of studies that examine primary care, the setting where the majority of patients in the U.S. receive treatment.

Released:
14-Apr-2019 5:05 PM EDT
Liuwhitecoat20191.JPG
  • Embargo expired:
    15-Apr-2019 10:00 AM EDT

Article ID: 711238

Rare but Important Gene Target Found in Many Tumor Types, Suggesting New Therapy Possible

Georgetown Lombardi Comprehensive Cancer Center

A consortium of researchers led by Georgetown Lombardi Comprehensive Cancer Center investigators have completed the largest analysis of a new gene fusion they believe is responsible for development of a wide spectrum of cancer types.

Released:
12-Apr-2019 2:00 PM EDT
Liuwhitecoat2019.JPG

Article ID: 709672

@LombardiCancer-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer

Georgetown Lombardi Comprehensive Cancer Center

The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end of numerous failed attempts to improve survival for those with the deadly disease.

Released:
18-Mar-2019 8:05 PM EDT
  • Embargo expired:
    7-Feb-2019 11:00 AM EST

Article ID: 707674

Study Finds HIV+ Cancer Patients Benefit From Immunotherapy

Georgetown Lombardi Comprehensive Cancer Center

The immunotherapy that has revolutionized treatment of many cancers appear to offer similar benefit to cancer patients living with HIV.

Released:
6-Feb-2019 4:05 PM EST
  • Embargo expired:
    29-Oct-2018 5:00 AM EDT

Article ID: 702700

Obese Mice Lose a Third of Their Fat Using a Natural Protein

Georgetown Lombardi Comprehensive Cancer Center

To the great surprise of cancer researchers in a Georgetown University-led study, a protein they investigated for its possible role in cancer turned out to be a powerful regulator of metabolism.

Released:
25-Oct-2018 5:00 AM EDT

Article ID: 700724

Use of Electrical Brain Stimulation to Foster Creativity Has Sweeping Implications

Georgetown Lombardi Comprehensive Cancer Center

In an article published in Creativity Research Journal, Georgetown researchers address neuro-ethical concerns associated with the increasing use of transcranial electrical stimulation (tES).

Released:
18-Sep-2018 12:00 PM EDT
  • Embargo expired:
    17-Aug-2018 9:00 AM EDT

Article ID: 698942

Georgetown Breast Cancer Advocates Make Their Case in Cancer Research Journal

Georgetown Lombardi Comprehensive Cancer Center

Georgetown Breast Cancer Advocates (GBCA), a volunteer group of survivors and other advocates who support and promote cancer research at Georgetown University, have published an article that underscores ways in which both the scientific and advocacy communities can foster a mutually beneficial collaboration.

Released:
15-Aug-2018 6:00 AM EDT

Showing results

110 of 80

Chat now!